跳至主要内容
临床试验/NCT03741686
NCT03741686已完成2 期

Beneficial Effects of Viscous Dietary Fiber From Konjac-Mannan in Subjects With the Insulin Resistance Syndrome

Unity Health Toronto0 个研究点目标入组 11 人开始时间: 1991年1月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
11
主要终点
change in systolic blood pressure

研究概览

简要总结

To study whether a diet high in fiber from Konjac-mannan (KJM) has an effect on metabolic control in individuals with insulin resistance syndrome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
45 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Impaired glucose tolerant
  • Clinical absent of CHD
  • BMI less than 30 kg/m2
  • Presence of full insulin resistance syndrome
  • Reduced HDL cholesterol
  • Elevated serum triglycerides
  • Moderate hypertension

排除标准

  • Regular smoking
  • Regular alcohol consumption
  • Family history of premature coronary heart disease
  • Hypothyroidism
  • Renal, hepatic or gastrointestinal disease
  • Taking medications for hyperglycemia
  • Taking medications for hyperlipidemia
  • Taking medications for hypertension

研究组 & 干预措施

Konjac-mannan

Experimental

Konjac-mannan fiber-enriched biscuits with NCEP Step II metabolically controlled diet.

干预措施: konjac glucomannan (Dietary Supplement)

Placebo

Placebo Comparator

wheat bran fiber biscuits with NCEP Step II metabolically controlled diet.

干预措施: wheat bran (Dietary Supplement)

结局指标

主要结局

change in systolic blood pressure

时间窗: change from baseline after 3 weeks, relative to control

change in fructosamine

时间窗: change from baseline after 3 weeks, relative to control

change in total:HDL cholesterol

时间窗: change from baseline after 3 weeks, relative to control

次要结局

  • change in total cholesterol(change from baseline after 3 weeks, relative to control)
  • change in LDL cholesterol(change from baseline after 3 weeks, relative to control)
  • change in glucose(change from baseline after 3 weeks, relative to control)
  • change in insulin(change from baseline after 3 weeks, relative to control)
  • change in HDL cholesterol(change from baseline after 3 weeks, relative to control)
  • change in apolipoprotein A-1(change from baseline after 3 weeks, relative to control)
  • change in apolipoprotain B(change from baseline after 3 weeks, relative to control)
  • change in diastolic blood pressure(change from baseline after 3 weeks, relative to control)
  • change in body weight(change from baseline after 3 weeks, relative to control)
  • change in apoB:ApoA-1(change from baseline after 3 weeks, relative to control)

研究者

申办方类型
Other
责任方
Sponsor

相似试验